Kate Newbold - Royal Marsden Hospital

More documents

Recommendations

Info

The Royal MarsdenAdvanced Stage disease• Stage III larynx-Induction chemotherapy and chemoradiotherapy• Stage IV larynx-Laryngectomy• Stage III-IV naso/oro/hypopharynx-Induction chemotherapy and chemoradiotherapy
The Royal MarsdenQuestionsWhat is the 2 year survival rate for stage I-II head andneck cancer ?A: 70%
Page 1 and 2: The Royal MarsdenDiagnosis - what h
Page 3: The Royal MarsdenEarly Stage diseas
Page 7 and 8: The Royal Marsden2 year survival ra
Page 9 and 10: •2 year overallsurvival 86.7%•2
Page 11 and 12: The Royal MarsdenChemoradiotherapy-
Page 13 and 14: The Royal MarsdenQuestionWhy do we
Page 15 and 16: The Royal MarsdenQuestionWhich shou
Page 17 and 18: The Royal MarsdenPreparation for Ch
Page 19 and 20: The Royal MarsdenRadiotherapy Plann
Page 21 and 22: The Royal MarsdenCT planning - 3D R
Page 23 and 24: The Royal MarsdenWhat is Intensity
Page 25 and 26: The Royal MarsdenLinear Accelerator
Page 27 and 28: The Royal MarsdenToxicity of radiot
Page 29 and 30: The Royal MarsdenToxicity of Radiot
Page 31 and 32: The Royal MarsdenXerostomia- Major
Page 33 and 34: The Royal MarsdenOsteoradionecrosis
Page 35 and 36: The Royal MarsdenImportance of Over
Page 37 and 38: The Royal MarsdenK. Kian Ang, 2001:
Page 39: The Royal MarsdenMDT- ENT- Maxillo-

Kate Newbold - Royal Marsden Hospital

Create successful ePaper yourself

Delete template?

Save as template?